Treatment of endometriosis with the novel selective progesterone receptor modulator (SPRM) asoprisnil
OA: bronze
CC0
⤵ 32 in-corpus citations
AI-generated summary
This paper investigated the efficacy and safety of the novel selective progesterone receptor modulator (SPRM) asoprisnil for treating endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
Cited by (32)
- Neuroimmunology of Endometriosis-Associated Pain and Its Psychological Aspects 2024
- Medical treatments of endometriosis: a review 2022
- Endometriosis diagnosis and medical treatment: Present and future 2021
- Selective Progesterone Receptor Modulators (SPRMs) and Androgen Receptor Modulators (SARMs) as Treatment for Benign Gynecologic Diseases 2021
- From pathogenesis to clinical practice: Emerging medical treatments for endometriosis 2018
- Medical treatment of endometriosis-related pain 2018
- Progesterone receptor modulators for endometriosis 2017
- Adenomyosis: a systematic review of medical treatment 2016
- Estrogen-progestins and progestins for the management of endometriosis 2016
- Hormonal therapy for endometriosis: from molecular research to bedside 2016
- An overview of early drug development for endometriosis 2015
- Endometriosis: alternative methods of medical treatment 2015
- Medical treatments for endometriosis-associated pelvic pain 2014
- Medikamentöse Therapie der Endometriose 2014
- Hormontherapie bei gynäkologischen, nichtmalignen Erkrankungen 2013
- Medikamentöse Therapie der Endometriose 2013
- Progesterone receptor antagonists and progesterone receptor modulators for endometriosis 2012
- The immninent dawn of SPRMs in obstetrics and gynecology 2012
- New trends for the medical treatment of endometriosis 2012
- Tratamiento de la endometriosis con 5mg o 25mg diarios de mifepristona durante 6 meses. Ensayo clínico aleatorizado, doble ciego 2011
- Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety 2011
- Medikamentöse Therapie der chronischen Endometriose 2011
- Pharmacological treatment of endometriosis: update from recent clinical trials 2011
- Chronische Endometriose: medikamentöse Therapie 2010
- Medical treatment of endometriosis 2009
- Endometriosis causing lower extremity deep vein thrombosis - case report and review of the literature 2009
- Treatment strategies for endometriosis 2008
- Investigational developments for the treatment of progesterone-dependent diseases 2008
- Progesterone receptor antagonists and selective progesterone receptor modulators: proven and potential clinical applications 2007
- The role of progestins in treating the pain of endometriosis 2006
- Role of nonhuman primate models in the discovery and clinical development of selective progesterone receptor modulators (SPRMs) 2006
- Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis 2005
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK